Latest Headlines

Latest Headlines

Massachusetts General Hospital pits BCG vaccine against Type I diabetes in Ph II

Another indication may be on the horizon for the generic BCG vaccine as Massachusetts General Hospital got an OK from the FDA for a Phase II trial of the vaccine's ability to help patients with Type I diabetes.

KKR-backed Panasonic Healthcare to buy Bayer diabetes device biz for almost $1.2B

The long-rumored sale of Bayer's diabetes device business to Panasonic Healthcare looks like it's finally coming to fruition after speculation stretching back at least to early this year. Bayer has said it will sell its Diabetes Care business to Panasonic Healthcare for €1.022 billion ($1.16 billion) in a deal expected to close during the first quarter of next year.

Intarcia readies for FDA in 2016 as it reports detailed Phase III data for once-yearly diabetes implant

Intarcia expects to report Phase III data during the second half of 2015 for the remaining two of its four pivotal trials in its program for once-yearly exenatide implant ITCA 650. If all goes well, it plans to head to the FDA next year. This week, the company offered detailed results at the American Diabetes Association (ADA) conference in Boston from June 5-8 for its two Phase III trials that had already reported data in October 2014.

Medtronic touts data in support of FDA approval of the latest MiniMed glucose monitor/pump

Medtronic presented additional data in support of FDA approval of its MiniMed640G glucose monitor and pump at the ongoing annual meeting of the American Diabetes Association in Boston.

Medtronic aims for diabetic consumer tech in deals with Samsung, Glooko and connected MiniMed clearance

Medtronic disclosed a trio of initiatives to make diabetic monitoring and management easier. These reflect the company's broader, ongoing commitment to transitioning into a focus on diabetic consumer wellness and include partnerships with consumer electronics company Samsung, diabetes data startup Glooko and an FDA clearance for MiniMed Connect.

Dexcom, Insulet partner with diabetes data startup Glooko as it expands into insulin pumps, CGMs

Glooko's mission is to integrate data from existing diabetes devices into an app for patients and a population management platform for payers and healthcare providers. It's diving into continuous glucose monitors and insulin pumps with a pair of deals--one for the Dexcom CGM and the other for the Insulet OmniPod pump.

Novo Nordisk spins cycling into diabetes awareness with pro racing team

More than two years ago, Novo Nordisk teamed with diabetes advocate and professional cyclist Phil Southerland to create Team Novo Nordisk, the first pro cycling team made entirely of athletes with diabetes. The 18-member team pedals into Philadelphia this week as part of the International Cycling Union Professional Continental Tour, but its mission has grown far beyond competition.

Philips collaborates with Dutch hospital to develop diabetic foot disease Dx

Royal Philips and the Academic Medical Center in Amsterdam, the Netherlands, will collaborate in a European multicenter trial of a new diagnostic technique to assess the results of minimally invasive treatment for diabetic foot and critical limb ischemia. The trial is slated to start this summer with final results expected in 2017.

Researchers from Boston Sci helping develop alternative to pancreas transplant

Irish researchers are developing an alternative to pancreas transplants as the race to treat diabetes heats up. They are developing a substance containing pancreatic cells embedded in a gel.

Eli Lilly leads Series B for startup with connected insulin pen, smartphone app combo

Eli Lilly has led a Series B round for San Diego, CA-based startup Companion Medical. The financing is expected to enable the completion of testing and 510(k) submission for its Bluetooth-enabled insulin pen and accompanying smartphone app. The amount of the financing was undisclosed.